Back to search
Severe Combined Immunodeficiency Due to ADA Deficiency
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Severe Combined Immunodeficiency Due to ADA Deficiency trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Severe Combined Immunodeficiency Due to ADA Deficiency trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase I/II trial of in vivo lentiviral gene therapy for treating adenosine deaminase severe combined immunodeficiency (ADA-SCID) using a self-inactiva…
The aim of this study is to assess the safety and efficacy of autologous transplantation of hematopoietic stem cells (CD34+ cells) from mobilized peripheral blo…
Adenosine deaminase (ADA) enzyme deficiency results in severe combined immunodeficiency (SCID), a fatal autosomal recessive inherited immune disorder. Strimveli…
This observational long-term follow-up study is designed to collect safety and efficacy data from ADA-SCID patients previously treated with autologous ex vivo g…